×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Liver Cancer

Jessica Skarzynski
For Liver Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
Kristie L. Kahl
Frontline treatment with Opdivo improved overall survival and response rates among patients with advanced hepatocellular carcinoma, however, the trial missed its primary endpoint.
Sonya Collins
As immunotherapies emerge in the treatment of liver cancer, experts examine whether two or more is better than one.
Jessica Skarzynski
Taking aspirin was found to improve liver function and extend survival among patients with hepatocellular carcinoma – the most common primary liver cancer.
Kristie L. Kahl
Researchers at Roswell Park Comprehensive Cancer Center found a biomarker that may help to determine which patients with hepatocellular carcinoma will respond to treatment with Nexavar, leading to more individualized treatment options.
Katie Kosko
A team of researchers examine funding among different cancer types, exposing disparities in cervical, colon, endometrial, liver and bile duct, lung, ovarian and pancreatic cancer.
 
Jessica Skarzynski
With a wealth of drugs available for the treatment of liver cancer, one expert explained how combination therapy may be where the future is headed.
Matthew Loxton
Blue Faery provides patients with hepatocellular carcinoma and their caregivers a range of focused resources. The goal of Blue Faery’s patient community is to improve the quality of life for patients, support their caregivers and give them hope, information and a voice.
Jessica Skarzynski
The president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association discussed new initiatives and what’s on the horizon in the treatment of liver cancer.
Kristie L. Kahl
While advances have been made in the treatment landscape of hepatocellular carcinoma, researchers are now looking into the optimal sequence for which patients should be treated.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×